Ftse Mib
34.019,19
-0,49%
DAX
19.907,04
-0,01%
S&P 500
5.881,63
-0,43%
NASDAQ
19.310,79
-0,90%
Bitcoin
96.574,23
2,31%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Onconetix Inc (ONCO) Onconetix Inc (ONCO) Notizie

ONCO

Onconetix (ONCO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ONCO
DataOraFonteTitoloSimboloCompagnia
17/12/202412:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ONCOOnconetix Inc
13/12/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONCOOnconetix Inc
12/12/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCOOnconetix Inc
12/12/202423:00GlobeNewswire Inc.Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent FilingNASDAQ:ONCOOnconetix Inc
11/12/202423:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ONCOOnconetix Inc
11/12/202412:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ONCOOnconetix Inc
15/11/202417:25Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ONCOOnconetix Inc
15/11/202416:45Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONCOOnconetix Inc
01/11/202422:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ONCOOnconetix Inc
01/11/202421:56Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ONCOOnconetix Inc
31/10/202421:20Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:ONCOOnconetix Inc
18/10/202422:10Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:ONCOOnconetix Inc
17/10/202417:53Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ONCOOnconetix Inc
09/10/202423:16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONCOOnconetix Inc
03/10/202422:45GlobeNewswire Inc.Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of CreditNASDAQ:ONCOOnconetix Inc
03/10/202415:05GlobeNewswire Inc.Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of CreditNASDAQ:ONCOOnconetix Inc
01/10/202422:35Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:ONCOOnconetix Inc
01/10/202401:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCOOnconetix Inc
27/09/202421:54Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ONCOOnconetix Inc
26/09/202422:08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ONCOOnconetix Inc
26/09/202412:16Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ONCOOnconetix Inc
20/09/202417:45GlobeNewswire Inc.Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of StockholdersNASDAQ:ONCOOnconetix Inc
03/09/202421:11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCOOnconetix Inc
29/08/202413:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCOOnconetix Inc
01/08/202422:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ONCOOnconetix Inc
22/07/202423:00Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:ONCOOnconetix Inc
15/07/202412:00GlobeNewswire Inc.Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross ProceedsNASDAQ:ONCOOnconetix Inc
11/07/202414:17GlobeNewswire Inc.Onconetix Announces Exercise of Warrants for $1.11 Million Gross ProceedsNASDAQ:ONCOOnconetix Inc
13/02/202412:00GlobeNewswire Inc.Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of DirectorsNASDAQ:ONCOOnconetix Inc
18/12/202313:00GlobeNewswire Inc.Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™NASDAQ:ONCOOnconetix Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ONCO

La tua Cronologia

BIT
NSCITA2LQSN2
Kreditanstalt fur Wieder...
BIT
UI336C
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network